Eupraxia Pharmaceuticals Common Stock Market Value
| EPRX Stock | 3.41 0.08 2.29% |
| Symbol | Eupraxia |
Eupraxia Pharmaceuticals 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Eupraxia Pharmaceuticals' pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Eupraxia Pharmaceuticals.
| 10/27/2024 |
| 11/26/2024 |
If you would invest 0.00 in Eupraxia Pharmaceuticals on October 27, 2024 and sell it all today you would earn a total of 0.00 from holding Eupraxia Pharmaceuticals Common or generate 0.0% return on investment in Eupraxia Pharmaceuticals over 30 days.
Eupraxia Pharmaceuticals Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Eupraxia Pharmaceuticals' pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Eupraxia Pharmaceuticals Common upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 4.38 | |||
| Information Ratio | 0.0717 | |||
| Maximum Drawdown | 30.52 | |||
| Value At Risk | (6.39) | |||
| Potential Upside | 7.93 |
Eupraxia Pharmaceuticals Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Eupraxia Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Eupraxia Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use Eupraxia Pharmaceuticals historical prices to predict the future Eupraxia Pharmaceuticals' volatility.| Risk Adjusted Performance | 0.0826 | |||
| Jensen Alpha | 0.5703 | |||
| Total Risk Alpha | (0.31) | |||
| Sortino Ratio | 0.0829 | |||
| Treynor Ratio | (0.65) |
Eupraxia Pharmaceuticals Backtested Returns
Eupraxia Pharmaceuticals appears to be very risky, given 3 months investment horizon. Eupraxia Pharmaceuticals secures Sharpe Ratio (or Efficiency) of 0.11, which denotes the company had a 0.11% return per unit of risk over the last 3 months. By reviewing Eupraxia Pharmaceuticals' technical indicators, you can evaluate if the expected return of 0.54% is justified by implied risk. Please utilize Eupraxia Pharmaceuticals' Coefficient Of Variation of 1030.92, downside deviation of 4.38, and Mean Deviation of 3.55 to check if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Eupraxia Pharmaceuticals holds a performance score of 8. The firm shows a Beta (market volatility) of -0.74, which means possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Eupraxia Pharmaceuticals are expected to decrease at a much lower rate. During the bear market, Eupraxia Pharmaceuticals is likely to outperform the market. Please check Eupraxia Pharmaceuticals' value at risk, as well as the relationship between the kurtosis and market facilitation index , to make a quick decision on whether Eupraxia Pharmaceuticals' price patterns will revert.
Auto-correlation | 0.71 |
Good predictability
Eupraxia Pharmaceuticals Common has good predictability. Overlapping area represents the amount of predictability between Eupraxia Pharmaceuticals time series from 27th of October 2024 to 11th of November 2024 and 11th of November 2024 to 26th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Eupraxia Pharmaceuticals price movement. The serial correlation of 0.71 indicates that around 71.0% of current Eupraxia Pharmaceuticals price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.71 | |
| Spearman Rank Test | 0.81 | |
| Residual Average | 0.0 | |
| Price Variance | 0.06 |
Eupraxia Pharmaceuticals lagged returns against current returns
Autocorrelation, which is Eupraxia Pharmaceuticals pink sheet's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Eupraxia Pharmaceuticals' pink sheet expected returns. We can calculate the autocorrelation of Eupraxia Pharmaceuticals returns to help us make a trade decision. For example, suppose you find that Eupraxia Pharmaceuticals has exhibited high autocorrelation historically, and you observe that the pink sheet is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Eupraxia Pharmaceuticals regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Eupraxia Pharmaceuticals pink sheet is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Eupraxia Pharmaceuticals pink sheet is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Eupraxia Pharmaceuticals pink sheet over time.
Current vs Lagged Prices |
| Timeline |
Eupraxia Pharmaceuticals Lagged Returns
When evaluating Eupraxia Pharmaceuticals' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Eupraxia Pharmaceuticals pink sheet have on its future price. Eupraxia Pharmaceuticals autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Eupraxia Pharmaceuticals autocorrelation shows the relationship between Eupraxia Pharmaceuticals pink sheet current value and its past values and can show if there is a momentum factor associated with investing in Eupraxia Pharmaceuticals Common.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Eupraxia Pink Sheet Analysis
When running Eupraxia Pharmaceuticals' price analysis, check to measure Eupraxia Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Eupraxia Pharmaceuticals is operating at the current time. Most of Eupraxia Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Eupraxia Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Eupraxia Pharmaceuticals' price. Additionally, you may evaluate how the addition of Eupraxia Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.